Wearable Medical Devices: Technologies and Global Markets

Report Highlights

The global market for wearable medical devices was valued at $35.6 billion in 2023. This market is estimated to grow from $45.0 billion in 2024 to $151.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.5% from 2024 through 2029.

Report Includes

• 39 data tables and 62 additional tables
• An analysis of the global markets for wearable medical devices and technologies
• Analyses of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, forecasts for 2029, and projected CAGRs through 2029
• Estimates of the current market size and revenue prospects, along with a market share analysis based on product type, application, sales channel, and region
• Facts and figures pertaining to market dynamics, current and emerging technologies, regulatory scenarios and reimbursement policies, and the expected impact of macroeconomic factors
• Assessment of technologies in development and the probability of their successful commercialization in the next five years
• Overview of sustainability trends and ESG developments in the industry, with a focus on consumer attitudes, companies’ ESG score rankings and their ESG practices
• An analysis of the industry structure, including companies’ market shares, merger and acquisition activity, and venture funding
• Profiles of the leading companies, including Medtronic, Abbott Laboratories, GE HealthCare, Philips Healthcare, Masimo Corp., and Dexcom Inc.

Report Scope

This research report covers the global market for wearable medical devices segmented based on product, application and sales channel. It incorporates an in-depth analysis of the wearable medical devices market, including market estimations and trends through 2029. By geographical region, the market is divided into North America, Europe, Asia-Pacific and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.

Major players, technologies, applications, market dynamics and geographic opportunities are discussed in detail in the report. This report also examines various analytical frameworks such as PESTEL analysis, ESG analysis, regulatory landscape, reimbursement scenario and competitive analysis, which will aid the companies in devising their strategic plan of action.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.